These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9217349)

  • 1. The risk of relapse after multidrug therapy in leprosy.
    Desikan KV
    Lepr Rev; 1997 Jun; 68(2):114-6. PubMed ID: 9217349
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse rates following leprosy multidrug therapy.
    Suite M
    West Indian Med J; 2000 Sep; 49(3):210-1. PubMed ID: 11076211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in leprosy clinical pattern after multidrug therapy implementation.
    Martelli CM; Andrade AL; Grossi MA; Leboeuf MA; Lombardi C; Zicker F
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):95-7. PubMed ID: 7730726
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidrug therapy in the control of leprosy. A field study.
    Becx-Bleumink M
    Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of relapse in leprosy after fixed-duration multidrug therapy.
    Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse of leprosy after multidrug therapy.
    Dasananjali K
    J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success of the WHO multidrug therapy?
    Becx-Bleumink M
    Trop Geogr Med; 1994; 46(2):61-4. PubMed ID: 8079392
    [No Abstract]   [Full Text] [Related]  

  • 8. A computer simulation of the effect of multidrug therapy on the incidence of leprosy.
    Lechat MF; Misson CB; Vanderveken M; Vellut CM; Declercq EE
    Ann Soc Belg Med Trop; 1987 Mar; 67(1):59-65. PubMed ID: 3632078
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapse rates amongst the multidrug therapy-treated leprosy patients.
    Umarane SB
    Indian J Lepr; 2001; 73(4):362-4. PubMed ID: 11898471
    [No Abstract]   [Full Text] [Related]  

  • 10. Workshop on multidrug therapy of leprosy in low-endemic areas: an evaluation.
    Indian J Lepr; 1991; 63(1):132-5. PubMed ID: 1919083
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of leprosy. Report of a WHO Study Group.
    World Health Organ Tech Rep Ser; 1994; 847():1-24. PubMed ID: 7817604
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug therapeutic challenges in leprosy.
    Jain S; Sehgal VN
    Int J Dermatol; 1997 Jul; 36(7):493-6. PubMed ID: 9268743
    [No Abstract]   [Full Text] [Related]  

  • 13. Rate of relapse and reactions in MB leprosy patients after 24 and 12 months of MDT in Maharashtra.
    Deshpande J; Chougule SG; Thakar UH; Revankar CR
    Indian J Lepr; 2004; 76(3):229-30. PubMed ID: 15835608
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of relapse in multibacillary leprosy.
    Lienhardt C; Jamet P; Sow SO
    Lancet; 1995 Mar; 345(8951):736. PubMed ID: 7885160
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of relapse in multibacillary leprosy.
    Jakeman P
    Lancet; 1995 Jan; 345(8941):4-5. PubMed ID: 7799708
    [No Abstract]   [Full Text] [Related]  

  • 16. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of leprosy and response to treatment in Hong Kong.
    Ho CK; Lo KK
    Hong Kong Med J; 2006 Jun; 12(3):174-9. PubMed ID: 16760543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
    Jamet P; Ji B
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy disabilities: the impact of multidrug therapy (MDT).
    Ladhani S
    Int J Dermatol; 1997 Aug; 36(8):561-72. PubMed ID: 9329883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.